Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2024-A02034-43 | Registry Identifier | N° ID-RCB |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
SPECTRE is a prospective longitudinal study in order to identify whether patients with different degrees of motor recovery are distinguished by distinct brain post-stroke plasticity patterns in the acute and sub-acute phases. This study allows close longitudinal follow-up of patients with severe clinical motor impairment using functional MRI to study cerebral neuroplasticity after ischemic stroke in the acute and sub-acute phase in patients with upper limb motor impairement, taking into account prognostic criteria used in current practice.
Patients are recruited as they are admitted to the neurovascular department. The SAFE score from the Stinear study is taken on Day 3 of the stroke, followed by motor evoked potentials between Day 3-Day 7 of the stroke, for a equal distribution of patients into three prognostic groups according to the PREP2 algorithm (good, limited and poor).
Longitudinal follow-up with clinical scores and functional MRI at Day 7-Day 10, Day 30, Month 3 and Month 6 of stroke.
Patients will ultimately be classified and analyzed according to their effective motor recovery at 6 months, using the Fugl-Meyer score.
The investigators will then conduct a comprehensive analysis of brain connectivity, examining both the anatomical structure of the brain, its functional activity and the dynamic interactions between certain regions of interest over time.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patients | Experimental | Three prognostic groups according to the PREP2 algorithm (good, limited and poor). 21 evaluable patients divided into 3 balanced prognostic groups. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Clinical scores and functional MRI | Other | Motor evoked potentials between Day 3-Day 7 of the stroke, for a equal distribution of patients into three prognostic groups according to the PREP2 algorithm (good, limited and poor). Longitudinal follow-up with clinical scores and functional MRI at Day 7-Day 10, Day 30, Month 3 and Month 6 of stroke. |
| Measure | Description | Time Frame |
|---|---|---|
| Changes in effective connectivity of Brain data (fMRI activity and CST tractography) | Descriptive analysis of topological measures of effective connectivity graphs as a function of effective motor recovery (Fugl-Meyer score - Upper Extremity) at 6 months. The Fugl-Meyer upper limb motor subscale has a maximum score of 66. The effective Fugl Meyer score classifies motor recovery into 3 categories (mild, moderate and severe). A Fugl Meyer score of 0-28 is classified as severe, 29-42 as moderate and 42-66 as mild. | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Changes in Effective connectivity of brain data | Longitudinal analysis of topological measures of effective connectivity graphs (between Region of interest (ROIs)) according to recovery categories defined by the Fugl-Meyer score. | From Day 7-Day 10 to 6 months |
| Changes in Structural connectivity of brain data |
Not provided
Inclusion Criteria:
Non-Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Maud GUILLEN, Md | Contact | 299284122 | +33 | maud.guillen@chu-rennes.fr |
| Isabelle LEROYER | Contact | 299284321 | +33 | isabelle.leroyer@chu-rennes.fr |
| Name | Affiliation | Role |
|---|---|---|
| Maud GUILLEN, Md | RENNES CHU | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Rennes Chu | Rennes | France | 35033 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001927 | Brain Diseases |
| D000083242 | Ischemic Stroke |
| D020521 | Stroke |
| D020520 | Brain Infarction |
| ID | Term |
|---|---|
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
| D002561 | Cerebrovascular Disorders |
| D014652 | Vascular Diseases |
Not provided
Not provided
Single-center, prospective, cohort, interventional study with minimal risks and constraints according to the Loi Jardé (RIPH2).
Longitudinal follow-up of patients.
Not provided
Not provided
Not provided
Not provided
|
Analysis of topological measures of structural connectivity graphs according to recovery categories defined by the Fugl-Meyer score. |
| From Day7-Day 10 to 6 months |
| Changes in Modification of brain activity of brain data | Longitudinal analysis of brain activity (expressed as variation in BOLD hemodynamic response) at rest and during a motor task (between ROIs) according to recovery categories defined by the Fugl-Meyer score. | From Day 7-Day 10 to 6 months |
| Changes in Ipsilesional / contralesional laterality index of brain data | Longitudinal analysis of the ipsilesional/counterlesional laterality index of activations in sensorimotor areas according to recovery categories defined by the Fugl-Meyer score. | From Day 7-Day 10 to 6 months |
| Changes in perfusion of brain data | Longitudinal analysis of perfusion (infratentorial, interhemispheric, intrahemispheric) according to recovery categories defined by the Fugl-Meyer score. | From Day 7-Day 10 to 6 months |
| Changes in Degree of corticospinal FA ratio of brain data | Longitudinal analysis of the degree of FA ratio of the cortico-spinal tract (injured hemisphere / healthy hemisphere) according to the recovery categories defined by the Fugl-Meyer score. | From Day 7-Day 10 to 6 months |
| Changes in patients' clinical profile in terms of motricity | Changes in Motor scores Motor index for upper and lower limbs according to recovery categories defined by the Fugl-Meyer score. The Motricity Index can be used to assess the motor impairment in a patient who has had a stroke. This test includes a motor test on the upper limb with a score from 0 to 100, combined with a motor test on the lower limb with a score from 0 to 100. The sum of these two scores is divided by 2 for a total out of 100. A high score indicates good recovery." | 6 months |
| Changes in patients' clinical profile in terms of motricity | Changes in Action Research Arm Test (ARAT) score according to recovery categories defined by the Fugl-Meyer score. The total score on the ARAT ranges from 0 to 57, with the lowest score indicating that no movements can be performed, and the upper score indicating normal performance. Thus, higher scores will indicate better performance. The ARAT scores is a continuous measure, with no categorical cutoff scores. | 6 months |
| Changes in patients' clinical profile in quality of life | Progression in The Stroke Impact Scale (SIS) score according to recovery categories defined by the Fugl-Meyer score. The SIS contains 59 items measuring eight domains: strength (4 items), hand functionality (5 items), ADL / IADL (10 items), mobility (9 items), communication (7 items), emotions (9 items), memory / thinking (7 items), and social participation (8 items). A final item assessing overall stroke recovery is asked of the patient (score out of 100). The minimum score is 60, the maximum is 300. A high score indicates a good quality of life. | 6 months |
| Changes in patients' clinical profile in independence | Progression in The Composite Functional Independence Scale (MIF) score according to recovery categories defined by the Fugl-Meyer score. The MIF consists of 18 items measuring patients' performance in performance in activities of daily living, including cognitive and relational aspects. For each item (from 1 to 18), the therapist chooses the patient's level of incapacity from 1 (total assistance) to 7 (total independence). The total score is calculated by adding up the disability level figures for each item. The minimum score is 18, the maximum is 126. A high score indicates complete independence. | 6 months |
| Changes in patients' clinical profile in spasticity | Progression in Changes in Tardieu Scale according to recovery categories defined by the Fugl-Meyer score. The Tardieu Scale are clinical measures of muscle spasticity in patients with neurological conditions. The Tardieu Scale quantify spasticity by assessing the muscle's response to stretch applied at given velocities. The examiner evaluates the muscle group's reaction to stretch at a specified velocity with 2 parameters: X (quality of muscle reaction) and Y (angle of muscle reaction). | 6 months |
| Changes in clinical profile in terms of motor skills | Changes in Fugl-Meyer Assesment - Upper Extremity (FMA-UE) according to recovery categories defined by the Fugl-Meyer score. The FMA assesses motor impairment of the upper and lower limb, balance, sensitivity, passive joint mobility and pain on mobilization following stroke. The Fugl-Meyer upper limb motor subscale has a maximum score of 66. The effective Fugl Meyer score classifies motor recovery into 3 categories (mild, moderate and severe). A Fugl Meyer score of 0-28 is classified as severe, 29-42 as moderate and 42-66 as mild. | Day 7-Day 10 |
| Changes in clinical profile in terms of motor skills | Changes in Fugl-Meyer Assesment - Upper Extremity (FMA-UE) according to recovery categories defined by the Fugl-Meyer score. The FMA assesses motor impairment of the upper and lower limb, balance, sensitivity, passive joint mobility and pain on mobilization following stroke. The Fugl-Meyer upper limb motor subscale has a maximum score of 66. The effective Fugl Meyer score classifies motor recovery into 3 categories (mild, moderate and severe). A Fugl Meyer score of 0-28 is classified as severe, 29-42 as moderate and 42-66 as mild. | Day 30 |
| Changes in clinical profile in terms of motor skills | Changes in Fugl-Meyer Assesment - Upper Extremity (FMA-UE) according to recovery categories defined by the Fugl-Meyer score. The FMA assesses motor impairment of the upper and lower limb, balance, sensitivity, passive joint mobility and pain on mobilization following stroke. The Fugl-Meyer upper limb motor subscale has a maximum score of 66. The effective Fugl Meyer score classifies motor recovery into 3 categories (mild, moderate and severe). A Fugl Meyer score of 0-28 is classified as severe, 29-42 as moderate and 42-66 as mild. | 3 months |
| Changes in clinical profile in terms of motor skills | Changes in Fugl-Meyer Assesment - Upper Extremity (FMA-UE) according to recovery categories defined by the Fugl-Meyer score. The FMA assesses motor impairment of the upper and lower limb, balance, sensitivity, passive joint mobility and pain on mobilization following stroke. The Fugl-Meyer upper limb motor subscale has a maximum score of 66. The effective Fugl Meyer score classifies motor recovery into 3 categories (mild, moderate and severe). A Fugl Meyer score of 0-28 is classified as severe, 29-42 as moderate and 42-66 as mild. | 6 months |
| Changes in clinical profile in terms of of global impairment | Changes in National Institutes of Health Stroke Scale (NIHSS) according to recovery categories defined by the Fugl-Meyer score. This scale assesses level of consciousness, extraocular movements, field of vision, facial muscle function, extremity strength, sensory function, coordination (ataxia), language (aphasia), speech (dysarthria) and hemineglect (neglect). Total NIHSS scores range from 0 to 42, with higher values reflecting more severe brain damage. Stroke severity is defined according to threshold scores as follows: > 25 - severe neurological deficits, 5-14 - moderate neurological deficits, < 5 - mild deficits. | Day 7-Day 10 |
| Changes in clinical profile in terms of of global impairment | Changes in National Institutes of Health Stroke Scale (NIHSS) according to recovery categories defined by the Fugl-Meyer score. This scale assesses level of consciousness, extraocular movements, field of vision, facial muscle function, extremity strength, sensory function, coordination (ataxia), language (aphasia), speech (dysarthria) and hemineglect (neglect). Total NIHSS scores range from 0 to 42, with higher values reflecting more severe brain damage. Stroke severity is defined according to threshold scores as follows: > 25 - severe neurological deficits, 5-14 - moderate neurological deficits, < 5 - mild deficits. | Day 30 |
| Changes in clinical profile in terms of of global impairment | Changes in National Institutes of Health Stroke Scale (NIHSS) according to recovery categories defined by the Fugl-Meyer score. This scale assesses level of consciousness, extraocular movements, field of vision, facial muscle function, extremity strength, sensory function, coordination (ataxia), language (aphasia), speech (dysarthria) and hemineglect (neglect). Total NIHSS scores range from 0 to 42, with higher values reflecting more severe brain damage. Stroke severity is defined according to threshold scores as follows: > 25 - severe neurological deficits, 5-14 - moderate neurological deficits, < 5 - mild deficits. | 3 months |
| Changes in clinical profile in terms of of global impairment | Changes in National Institutes of Health Stroke Scale (NIHSS) according to recovery categories defined by the Fugl-Meyer score. This scale assesses level of consciousness, extraocular movements, field of vision, facial muscle function, extremity strength, sensory function, coordination (ataxia), language (aphasia), speech (dysarthria) and hemineglect (neglect). Total NIHSS scores range from 0 to 42, with higher values reflecting more severe brain damage. Stroke severity is defined according to threshold scores as follows: > 25 - severe neurological deficits, 5-14 - moderate neurological deficits, < 5 - mild deficits. | 6 months |
| Changes in neurological events | Changes in significant clinical worsening defined by a worsening of the NIHSS score by 4 points, epileptic seizure. This scale assesses level of consciousness, extraocular movements, field of vision, facial muscle function, extremity strength, sensory function, coordination (ataxia), language (aphasia), speech (dysarthria) and hemineglect (neglect). Total NIHSS scores range from 0 to 42, with higher values reflecting more severe brain damage. Stroke severity is defined according to threshold scores as follows: > 25 - severe neurological deficits, 5-14 - moderate neurological deficits, < 5 - mild deficits. | From enrollment to the end of evaluation at 6 months |
| D002318 | Cardiovascular Diseases |
| D002545 | Brain Ischemia |
| D007238 | Infarction |
| D007511 | Ischemia |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D009336 | Necrosis |